Back to Top
Go Back
Journal Photo for Journal of the American College of Cardiology
Peer reviewed only Open Access

Journal of the American College of Cardiology (JACC)

Publisher : Elsevier (USA)
Cardiology Cardiovascular Medicine
Claim Your Journal Get PRC Visit Website
e-ISSN 1558-3597
p-ISSN 0735-1097
Issue Frequency Monthly
Impact Factor 24
Est. Year 1983
Mobile 2123098100
Country United States
Language English
APC YES
Impact Factor Assignee Google Scholar
Email nlinfo@sciencedirect.com

Journal Descriptions

A Journal of the American College of Cardiology As the leader in its field, JACC publishes original peer-reviewed clinical and experimental reports on all aspects of cardiovascular disease. Topics covered include coronary artery and valve disease, congenital heart defects, vascular surgery, cardiomyopathy, drug treatment, new diagnostic techniques, findings from the laboratory, and large multi-center studies of new therapies. JACC also publishes abstracts of papers presented at the annual scientific sessions of the American College of Cardiology and the reports and recommendations of the Bethesda Conferences on current topics in cardiovascular disease. Benefits to authors We also provide many author benefits, such as a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services. Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center. JACC has also launched a series of specialist titles you are welcome to submit to: JACC: Advances JACC: Asia JACC: Basic to Translational Science JACC: CardioOncology JACC: Cardiovascular Imaging JACC: Cardiovascular Interventions JACC: Case Reports JACC: Clinical Electrophysiology JACC: Heart Failure

Journal of the American College of Cardiology (JACC) is :-

  • International, Peer-Reviewed, Open Access, Refereed, Cardiology, Cardiovascular Medicine , Online or Print , Monthly Journal

  • UGC Approved, ISSN Approved: P-ISSN P-ISSN: 0735-1097, E-ISSN: 1558-3597, Established: 1983, Impact Factor: 24
  • Does Not Provide Crossref DOI

  • Indexed in: Scopus

  • Not indexed in WoS, DOAJ, PubMed, UGC CARE

Indexing

Role In Research Journal

C. Noel Bairey Merz Profile Photo
C. Noel Bairey Merz
Editorial Board Member
C. Noel Bairey Merz Profile Photo
C. Noel Bairey Merz
Editorial Consultant

Publications of JACC

ALIROCUMAB EFFICACY AND SAFETY IN PATIENTS WITH HYPERCHOLESTEROLEMIA AND WITH OR WITHOUT CLINICAL ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: POOLED ANALY...
Peter B Jones March, 2017
Background: The alirocumab (ALI) ODYSSEY clinical trial program recruited patients with hypercholesterolemia, ∼70% of whom had atherosclerotic cardiovascular disease (ASCVD) and were at ve...
UTILITY OF 3-DIMENSIONAL ECHOCARDIOGRAPHY IN PREDICTING THE IMMEDIATE OUTCOME OF PERCUTANEOUS TRANSVENOUS MITRAL COMMISSUROTOMY
Balram Bhargava April, 2011
Background: Despite over 2 decades of percutaneous transvenous mitral commissurotomy (PTMC), the prediction of success/complications remains imperfect. We assessed the utility of 3-dimensio...
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Asso...
C. Noel Bairey Merz December, 2014
The medical profession should play a central role in evaluating the evidence related to drugs, devices, and procedures for the detection, management, and prevention of disease. When proper...
Insights From the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study: Part II: Gender Differences in Presentation, Diagnosis, and Out...
C. Noel Bairey Merz February, 2006
Coronary heart disease is the leading cause of death and disability in the U.S., but recent advances have not led to declines in case fatality rates for women. The current review highlights ...
Insights From the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study: Part I: Gender Differences in Traditional and Novel Risk Factor...
C. Noel Bairey Merz February, 2006
Despite a dramatic decline in mortality over the past three decades, coronary heart disease is the leading cause of death and disability in the U.S. Importantly, recent advances in the field...
Women and Ischemic Heart Disease: Evolving Knowledge
C. Noel Bairey Merz January, 2009
Evolving knowledge regarding sex differences in coronary heart disease is emerging. Given the lower burden of obstructive coronary artery disease (CAD) and preserved systolic function in wom...
Coronary Microvascular Reactivity to Adenosine Predicts Adverse Outcome in Women Evaluated for Suspected Ischemia: Results From the National Heart, Lu...
C. Noel Bairey Merz June, 2010
Objectives: We investigated whether coronary microvascular dysfunction predicts major adverse outcomes during follow-up among women with signs and symptoms of ischemia. Background: Altere...
The Women’s Ischemia Syndrome Evaluation (WISE) Study: protocol design, methodology and feasibility report
C. Noel Bairey Merz May, 1999
OBJECTIVES The Women’s Ischemia Syndrome Evaluation (WISE) is a National Heart, Lung and Blood Institute–sponsored, four-center study designed to: 1) optimize symptom evaluation and dia...
Contraceptive Hormone Use and Cardiovascular Disease
C. Noel Bairey Merz January, 2009
Contraceptive hormones, most commonly prescribed as oral contraceptives (OCs), are a widely utilized method to prevent ovulation, implantation, and, therefore, pregnancy. The Women's Health ...
Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study
C. Noel Bairey Merz February, 2003
Objectives: We sought to evaluate hypoestrogenemia of hypothalamic origin and its association with angiographic coronary artery disease (CAD) in premenopausal women. Background: Coronary ...